期刊文献+

临床使用预混胰岛素类似物治疗糖尿病的依从性

Clinical compliance of premixed insulin analogues as therapy for diabetes
下载PDF
导出
摘要 研究显示:控制血糖,实现糖化血红蛋白(HbA1c)达标,可以显著降低糖尿病慢性并发症的风险。为了实现良好的血糖控制,胰岛素也不断更新换代,经历了动物源性胰岛素、基因重组人胰岛素、人胰岛素类似物三个主要阶段。与人胰岛素相比,胰岛素类似物具有更快起效,低血糖发生率低,长效胰岛素类似物疗效更平稳等优势。目前临床上常用的有速效胰岛素类似物、长效胰岛素类似物和预混胰岛素类似物。其中预混胰岛素类似物每日注射2~3次,可以单独使用。
出处 《药品评价》 CAS 2012年第31期44-46,共3页 Drug Evaluation
  • 相关文献

参考文献15

  • 1UK Prospective Diabetes Study(UKPDS)Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes(UKPDS 33)[J].The Lancet,1998.837–853.
  • 2Shichiri M,Kishikawa H,Ohkubo Y. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients[J].Diabetes Care,2000.B21–29.
  • 3Hartman I. Insulin Analogs:Impact on Treatment Success,Satisfaction,Quality of Life,and Adherence[J].Clinical medicine&research,2008,(02):54-67.
  • 4Bowering K,Reed VA,Felicio J. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication:results of the PARADIGM study[J].Diabetic Medicine,2012.263-272.
  • 5Malone JK,Bai S,Campaigne BN. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes[J].Diabetic Medicine,2005.374-381.
  • 6Malone JK,Kerr LF,Campaigne BN. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin:a 16-week,randomized,open-label,crossover study in patients with type 2 diabetes beginning insulin therapy[J].Clinical Therapeutics,2004.2034-2044.
  • 7Raskin P,Allen E,Hollander P. Initiating insulin therapy in type 2 Diabetes:a comparison of biphasic and basal insulin analogs[J].Diabetes Care,2005.260-265.
  • 8Holman RR,Thorne KI,Farmer AJ. Addition of biphasic,prandial,or basal insulin to oral therapy in type 2 diabetes[J].New England Journal of Medicine,2007.1716-1730.
  • 9Mattoo V,Milicevic Z,Malone JK. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan[J].Diabetes Research and Clinical Practice,2003,(02):137-143.
  • 10Ishii H,James H,Anderson Jr. Improvement of glycemic control and quality-of-life by insulin lispro therapy:Assessing benefits by ITR-QOL questionnaires[J].Diabetes Research and Clinical Practice,2008.169–178.

二级参考文献2

  • 1Reynolds NA, Wagstaff AJ. Insulin aspart : a review of its use in the management of type 1 or 2 diabetesmellitus[J].Drugs, 2004, 64(17) :1957-1974.
  • 2Bretzel RG, Arnolds S,Medding J,et al. A direct efficacy and safe ty comparison of insulin aspart ,human soluble insulin,and human premix insulin(70/30) in patientswith type 2 diabetes [J]. Diabetes Care, 2004,27 : 1023-1027.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部